🇺🇸 FDA

Company profile · Sponsor

Odyssey

Odyssey Therapeutics

ODTX · NYSE biotech BOSTON, MA, USA
Pipeline
4
Drugs
3
Patents
1

Quick answer

Odyssey (ODTX) is a biotech company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 3 drugs, and 1 patent to this profile..

Company facts

Ticker ODTX
Exchange NYSE
Company type biotech
Headquarters BOSTON, MA, USA
SEC CIK 0001882782

Pipeline (4)

Search pipeline →

  1. OD-07656

    Odyssey

    Ulcerative Colitis (UC)

    phase 2 small molecule active

    1 trial

  2. OD-07656, OD-07656, Entyvio 300 mg powder for concentrate for solution for infusion

    Odyssey

    Moderately to Severely Active Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  3. OD-07656

    Odyssey

    Inflammatory Bowel Diseases

    phase 1 small molecule completed

    1 trial

  4. PRV-002

    Odyssey

    Traumatic Brain Injury (TBI)

    phase 1 small molecule completed

    1 trial

Drugs (3)

Search drugs →

  1. bethanechol chloride

    MYOTONACHOL

    INJECTION approved

  2. disulfiram

    DISULFIRAM

    ORAL approved

  3. nystatin

    NYSTATIN

    TOPICAL approved

Patents (1)

Search patents →

  1. US 7306914

    Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy

    Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Odyssey?

Odyssey (ODTX) is a biotech company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 3 drugs, and 1 patent to this profile..

What pipeline programs does Odyssey sponsor?

We track 4 ClinicalTrials.gov-linked programs for Odyssey, including OD-07656 and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Odyssey company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.